# CISO Global, Inc.: financial statements, quarterly

CISO · Nasdaq · CIK 1777319 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ciso.md) · [Financials](/companies/ciso/financials.md) · [Filings](/companies/ciso/filings.md) · [Insiders](/companies/ciso/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ciso/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [8.7](/filings/0001493152-24-046585.md) | [8.2 d](/filings/0001641172-25-001660.md) | [8.0](/filings/0001641172-25-010897.md) | [7.8](/filings/0001641172-25-023931.md) | [7.5](/filings/0001493152-25-022410.md) | [7.4 d](/filings/0001493152-26-013324.md) | [7.2](/filings/0001493152-26-023156.md) | [6.7](/filings/0001493152-26-038417.md) | [6.5](/filings/0001493152-25-022410.md) | [6.3 d](/filings/0001493152-26-013324.md) | [6.2](/filings/0001493152-26-023156.md) | [5.8](/filings/0001493152-26-038417.md) |
| Cost of revenue | $m | [6.8](/filings/0001493152-24-046585.md) | [7.2 d](/filings/0001641172-25-001660.md) | [7.3](/filings/0001641172-25-010897.md) | [6.9](/filings/0001641172-25-023931.md) | [6.5](/filings/0001493152-25-022410.md) | [5.6 d](/filings/0001493152-26-013324.md) | [5.4](/filings/0001493152-26-023156.md) | [5.1](/filings/0001493152-26-038417.md) | [4.9](/filings/0001493152-25-022410.md) | [4.5 d](/filings/0001493152-26-013324.md) | [4.4](/filings/0001493152-26-023156.md) | [4.4](/filings/0001493152-26-038417.md) |
| Gross profit | $m | [1.9](/filings/0001493152-24-046585.md) | [0.9 d](/filings/0001641172-25-001660.md) | [0.7](/filings/0001641172-25-010897.md) | [0.9](/filings/0001641172-25-023931.md) | [1.0](/filings/0001493152-25-022410.md) | [1.8 d](/filings/0001493152-26-013324.md) | [1.8](/filings/0001493152-26-023156.md) | [1.6](/filings/0001493152-26-038417.md) | [1.6](/filings/0001493152-25-022410.md) | [1.8 d](/filings/0001493152-26-013324.md) | [1.8](/filings/0001493152-26-023156.md) | [1.4](/filings/0001493152-26-038417.md) |
| Selling, general and administrative | $m | [4.4](/filings/0001493152-24-046585.md) | [4.3 d](/filings/0001641172-25-001660.md) | [4.0](/filings/0001641172-25-010897.md) | [3.6](/filings/0001641172-25-023931.md) | [3.1](/filings/0001493152-25-022410.md) | [2.4 d](/filings/0001493152-26-013324.md) | [2.7](/filings/0001493152-26-023156.md) | [2.6](/filings/0001493152-26-038417.md) | [2.6](/filings/0001493152-25-022410.md) | [2.7 d](/filings/0001493152-26-013324.md) | [2.3](/filings/0001493152-26-023156.md) | [2.4](/filings/0001493152-26-038417.md) |
| Operating income | $m | [(4.0)](/filings/0001493152-24-046585.md) | [(9.5) d](/filings/0001641172-25-001660.md) | [(4.9)](/filings/0001641172-25-010897.md) | [(4.2)](/filings/0001641172-25-023931.md) | [(3.5)](/filings/0001493152-25-022410.md) | [(1.9) d](/filings/0001493152-26-013324.md) | [(1.7)](/filings/0001493152-26-023156.md) | [(2.3)](/filings/0001493152-26-038417.md) | [(2.6)](/filings/0001493152-25-022410.md) | [(2.1) d](/filings/0001493152-26-013324.md) | [(1.4)](/filings/0001493152-26-023156.md) | [(1.5)](/filings/0001493152-26-038417.md) |
| Interest expense | $m | [0.8](/filings/0001493152-23-040568.md) | [1.0 d](/filings/0001493152-24-014818.md) | [0.7](/filings/0001641172-25-010897.md) | [0.6](/filings/0001641172-25-023931.md) | [1.2](/filings/0001493152-25-022410.md) | [3.0 d](/filings/0001493152-26-013324.md) | [8.2](/filings/0001641172-25-010897.md) | [0.7](/filings/0001493152-26-038417.md) | [0.1](/filings/0001493152-25-022410.md) | [0.1 d](/filings/0001493152-26-013324.md) | [0.1](/filings/0001493152-26-023156.md) | [0.1](/filings/0001493152-26-038417.md) |
| Income tax | $m | [0.0 d](/filings/0001493152-23-040568.md) | [0.0 d](/filings/0001493152-24-014818.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(5.5)](/filings/0001493152-24-046585.md) | [(10.6) d](/filings/0001641172-25-001660.md) | [(6.6)](/filings/0001641172-25-010897.md) | [(8.4)](/filings/0001641172-25-023931.md) | [(3.7)](/filings/0001493152-25-022410.md) | [(5.5) d](/filings/0001493152-26-013324.md) | [(5.4)](/filings/0001493152-26-023156.md) | [(3.0)](/filings/0001493152-26-038417.md) | [2.5](/filings/0001493152-25-022410.md) | [(2.2) d](/filings/0001493152-26-013324.md) | [(1.6)](/filings/0001493152-26-023156.md) | [(1.6)](/filings/0001493152-26-038417.md) |
| Diluted EPS | $ per share | [(0.47)](/filings/0001493152-24-046585.md) | not reported | [(0.55)](/filings/0001641172-25-010897.md) | [(0.69)](/filings/0001641172-25-023931.md) | [(0.32)](/filings/0001493152-25-022410.md) | not reported | [(0.38)](/filings/0001493152-26-023156.md) | [(0.09)](/filings/0001493152-26-038417.md) | [(0.05)](/filings/0001493152-25-022410.md) | not reported | [(0.04)](/filings/0001493152-26-023156.md) | [(0.04)](/filings/0001493152-26-038417.md) |
| Basic EPS | $ per share | [(0.47)](/filings/0001493152-24-046585.md) | not reported | [(0.55)](/filings/0001641172-25-010897.md) | [(0.69)](/filings/0001641172-25-023931.md) | [(0.32)](/filings/0001493152-25-022410.md) | not reported | [(0.38)](/filings/0001493152-26-023156.md) | [(0.09)](/filings/0001493152-26-038417.md) | [0.07](/filings/0001493152-25-022410.md) | not reported | [(0.04)](/filings/0001493152-26-023156.md) | [(0.04)](/filings/0001493152-26-038417.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.6](/filings/0001493152-24-046585.md) | [0.2](/filings/0001641172-25-001660.md) | [1.5](/filings/0001493152-24-020688.md) | [1.1](/filings/0001641172-25-023931.md) | [0.4](/filings/0001493152-25-022410.md) | [1.0](/filings/0001493152-26-013324.md) | [1.8](/filings/0001641172-25-010897.md) | [0.8](/filings/0001641172-25-023931.md) | [1.1](/filings/0001493152-25-022410.md) | [1.7](/filings/0001493152-26-038417.md) | [0.6](/filings/0001493152-26-023156.md) | [0.7](/filings/0001493152-26-038417.md) |
| Current assets | $m | [11.6](/filings/0001493152-23-040568.md) | [26.3](/filings/0001641172-25-001660.md) | [9.3](/filings/0001493152-24-020688.md) | [19.1](/filings/0001493152-24-031836.md) | [3.0](/filings/0001493152-24-046585.md) | [3.5](/filings/0001493152-26-013324.md) | [5.0](/filings/0001641172-25-010897.md) | [3.3](/filings/0001641172-25-023931.md) | [3.0](/filings/0001493152-25-022410.md) | [3.3](/filings/0001493152-26-038417.md) | [2.3](/filings/0001493152-26-023156.md) | [2.5](/filings/0001493152-26-038417.md) |
| Total assets | $m | [56.1](/filings/0001493152-23-040568.md) | [51.7](/filings/0001641172-25-001660.md) | [47.5](/filings/0001493152-24-020688.md) | [43.2](/filings/0001493152-24-031836.md) | [26.6](/filings/0001493152-24-046585.md) | [26.7](/filings/0001493152-26-013324.md) | [27.8](/filings/0001641172-25-010897.md) | [25.8](/filings/0001641172-25-023931.md) | [25.1](/filings/0001493152-25-022410.md) | [25.0](/filings/0001493152-26-038417.md) | [23.8](/filings/0001493152-26-023156.md) | [23.7](/filings/0001493152-26-038417.md) |
| Current liabilities | $m | [23.0](/filings/0001493152-23-040568.md) | [29.8](/filings/0001641172-25-001660.md) | [32.6](/filings/0001493152-24-020688.md) | [37.0](/filings/0001493152-24-031836.md) | [23.0](/filings/0001493152-24-046585.md) | [25.0](/filings/0001493152-26-013324.md) | [20.4](/filings/0001641172-25-010897.md) | [17.8](/filings/0001641172-25-023931.md) | [8.4](/filings/0001493152-25-022410.md) | [7.7](/filings/0001493152-26-038417.md) | [7.8](/filings/0001493152-26-023156.md) | [11.0](/filings/0001493152-26-038417.md) |
| Total liabilities | $m | [31.9](/filings/0001493152-23-040568.md) | [35.5](/filings/0001641172-25-001660.md) | [36.3](/filings/0001493152-24-020688.md) | [37.6](/filings/0001493152-24-031836.md) | [23.6](/filings/0001493152-24-046585.md) | [25.5](/filings/0001493152-26-013324.md) | [20.8](/filings/0001641172-25-010897.md) | [18.2](/filings/0001641172-25-023931.md) | [8.7](/filings/0001493152-25-022410.md) | [8.0](/filings/0001493152-26-038417.md) | [8.1](/filings/0001493152-26-023156.md) | [11.2](/filings/0001493152-26-038417.md) |
| Long-term debt | $m | [8.3](/filings/0001493152-23-040568.md) | [7.7](/filings/0001493152-24-014818.md) | [2.3](/filings/0001493152-24-020688.md) | [0.1](/filings/0001493152-24-031836.md) | [0.0](/filings/0001493152-24-046585.md) | [0.0](/filings/0001641172-25-001660.md) | [0.0](/filings/0001641172-25-010897.md) | [0.0](/filings/0001641172-25-023931.md) | [0.0](/filings/0001493152-25-022410.md) | [0.0](/filings/0001493152-26-013324.md) | not reported | not reported |
| Current portion of debt | $m | [4.8](/filings/0001493152-23-040568.md) | [5.7](/filings/0001493152-24-014818.md) | [12.8](/filings/0001493152-24-020688.md) | [12.7](/filings/0001493152-24-031836.md) | [11.9](/filings/0001493152-24-046585.md) | [11.7](/filings/0001641172-25-001660.md) | [10.5](/filings/0001641172-25-010897.md) | [9.9](/filings/0001641172-25-023931.md) | [2.0](/filings/0001493152-25-022410.md) | [2.3](/filings/0001493152-26-013324.md) | [2.1](/filings/0001493152-26-023156.md) | [4.1](/filings/0001493152-26-038417.md) |
| Shareholders' equity | $m | [24.2](/filings/0001493152-24-046585.md) | [16.1](/filings/0001493152-26-013324.md) | [11.2](/filings/0001641172-25-010897.md) | [5.6](/filings/0001493152-25-022410.md) | [3.0](/filings/0001493152-25-022410.md) | [1.1](/filings/0001493152-26-038417.md) | [7.0](/filings/0001493152-26-038417.md) | [7.6](/filings/0001493152-26-038417.md) | [16.3](/filings/0001493152-25-022410.md) | [14.8](/filings/0001493152-26-038417.md) | [13.8](/filings/0001493152-26-038417.md) | [12.5](/filings/0001493152-26-038417.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(1,386) d](/filings/0001493152-24-046585.md) | [784 d](/filings/0001641172-25-001660.md) | [(1,409)](/filings/0001641172-25-010897.md) | [(1,271) d](/filings/0001641172-25-023931.md) | [(903) d](/filings/0001493152-25-022410.md) | [(259) d](/filings/0001493152-26-013324.md) | [(2,954)](/filings/0001493152-26-023156.md) | [(2,350) d](/filings/0001493152-26-038417.md) | [(877) d](/filings/0001493152-25-022410.md) | [(1,792) d](/filings/0001493152-26-013324.md) | [(880)](/filings/0001493152-26-023156.md) | [(68.6) d](/filings/0001493152-26-038417.md) |
| Capital expenditure | $k | [17.4 d](/filings/0001493152-24-046585.md) | [47.4 d](/filings/0001641172-25-001660.md) | [75.6](/filings/0001641172-25-010897.md) | [7.5 d](/filings/0001641172-25-023931.md) | [0.0 d](/filings/0001493152-25-022410.md) | [0.0 d](/filings/0001493152-26-013324.md) | not reported | not reported | not reported | not reported | [8.9](/filings/0001493152-26-023156.md) | [0.0 d](/filings/0001493152-26-038417.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [142](/filings/0001493152-23-040568.md) | [9.8](/filings/0001493152-24-020688.md) | [10.9](/filings/0001493152-24-031836.md) | [11.8](/filings/0001493152-24-046585.md) | [12.0](/filings/0001641172-25-010897.md) | [12.2](/filings/0001641172-25-023931.md) | [11.7](/filings/0001493152-25-022410.md) | [14.2](/filings/0001493152-26-023156.md) | [31.8](/filings/0001493152-26-038417.md) | [33.7](/filings/0001493152-25-022410.md) | [45.2](/filings/0001493152-26-023156.md) | [45.4](/filings/0001493152-26-038417.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 45,525,655 at 2026-08-12, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-038417.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.